Counterfeit, Falsified and Substandard Medicines
Counterfeit and substandard medicines pose a considerable and growing threat to health security. The threat from counterfeit medicines is growing, particularly in poorer countries with weak regulatory mechanisms and poorly monitored distribution networks. Counterfeiting can be very profitable, and counterfeiters are increasingly sophisticated, making patients in developing countries, who usually have to buy medicines from their own resources, particularly vulnerable.
The Centre on Global Health Security is organizing this roundtable meeting, the objective of which is to help refine definitions of counterfeit, falsified and substandard medicines and to consider possible ways forward for the international community in addressing the health hazards posed by these medicines. Participants will include senior representatives from concerned international organisations, governments, industry, academia and civil society.
This event is strictly by invitation only and will be held under the Chatham House Rule.
The Chatham House Rule
To enable as open a debate as possible, this event will be held under the Chatham House Rule.